Start with habits and support you can keep using
NIDDK recommends continuing eating and activity habits after weight loss and arranging support when those habits are hard to maintain. The plan can include meals you like, movement you can continue and a way to respond to setbacks without treating one difficult week as failure.
A program can help with different needs: scheduled visits, a dietitian, a coach or simple reminders. Ask what is included and how long support lasts before comparing program charges.
Sources and scope (2)
- NIDDK: Eating and physical activity to lose or maintain weight
Patient guidance on maintaining eating and activity habits, seeking support and responding to setbacks after weight loss. It does not compare named medicines.
Checked
- NIDDK: Prescription medications to treat overweight and obesity
Patient overview with examples of established medicine classes and clinician discussion topics. The page states it was last reviewed June 2024, so its list is illustrative and not a complete 2026 product/formulary inventory.
Checked
Make a plan before changing a medicine
NIDDK says weight regain is common after stopping a weight-management medicine. The FDA labels for Wegovy and Imcivree include long-term maintenance uses in their distinct eligible populations. Neither label tells an individual when to stop, switch or reduce treatment.
Ask the prescriber which outcome the medicine is treating, how progress will be monitored and how follow-up will work if treatment changes. Confirm whether a new medicine would require a different form, starting dose, pharmacy or coverage decision.
- What is my maintenance goal and how will we measure it?
- What should I expect if this treatment stops?
- Who handles the next visit, prescription and pharmacy change?
- What fees or insurance approvals apply to the new plan?
Sources and scope (3)
- NIDDK: Prescription medications to treat overweight and obesity
Patient overview with examples of established medicine classes and clinician discussion topics. The page states it was last reviewed June 2024, so its list is illustrative and not a complete 2026 product/formulary inventory.
Checked
- FDA: Wegovy injection and tablet label
Distinct injection and tablet forms, labeled populations and long-term weight-reduction indications. It does not establish interchangeability or an individual treatment choice.
Checked
- FDA: Imcivree label
Indications and limits for acquired hypothalamic obesity, Bardet-Biedl syndrome and specified genetic deficiencies. These do not extend to general obesity.
Checked
What if food noise comes back?
- What changed
- Am I feeling hungry sooner, craving specific foods, or having food thoughts that are hard to set aside?
- When it started
- Did this start during treatment, after a refill gap, or after stopping? What medicine was I taking and when did I last take it?
- How it affects me
- Is it getting in the way of meals, concentration or daily life? What help would I like from my care team?
If you feel like the food noise is back, describe what you notice. Hunger is the body’s signal that it needs food. A craving is a strong desire for a particular food, even when you’re full. People often use “food noise” for persistent thoughts about food that are hard to set aside, such as thinking about the next meal while trying to work. These experiences can overlap.
While you’re still taking a GLP-1 medicine, appetite or food thoughts may feel different than they did at the start. In a small interview study, some people in the maintenance phase described stronger appetite or more thoughts about food than earlier in care. Share the change with your prescriber so you can look at the pattern together.
After stopping, some people report a return of hunger, cravings or frequent thoughts about food. In the STEP 1 extension, participants regained weight on average after semaglutide and the study’s lifestyle support ended. That study measured weight and health markers and leaves the timing and intensity of food thoughts uncertain.
Bring a brief timeline to your clinician and ask what support is available and when to check in again. Talk with your prescriber before changing or restarting the medicine.
Sources and scope (2)
- Patient interviews on eating during obesity medication treatment
Thirty-one interviews describe appetite, cravings and food-related thoughts during different treatment phases. The interviews cannot tell how often these experiences occur or predict an individual response.
Checked
- STEP 1 extension after withdrawal of semaglutide
Follow-up measured weight and related health markers after semaglutide and the trial’s lifestyle support ended. It did not establish when persistent thoughts about food return.
Checked
A plateau or some regain is a reason to review the plan
NIDDK explains that the body needs fewer calories after weight loss and that maintaining a lower weight can be difficult. A plateau does not by itself show that a medicine failed or that a more expensive plan will work better.
Bring a timeline of weight change, routine, medicines, side effects and any gaps in access to a follow-up visit. The clinician can review other health conditions and medicines that affect weight before discussing a change.
Sources and scope (2)
- NIDDK: Eating and physical activity to lose or maintain weight
Patient guidance on maintaining eating and activity habits, seeking support and responding to setbacks after weight loss. It does not compare named medicines.
Checked
- NIDDK: Prescription medications to treat overweight and obesity
Patient overview with examples of established medicine classes and clinician discussion topics. The page states it was last reviewed June 2024, so its list is illustrative and not a complete 2026 product/formulary inventory.
Checked
Know what your follow-up will cost and cover
- Timing
- When are my next visit and refill due?
- Possible interruption
- What will I do if the refill price, availability or coverage changes?
- Point of contact
- Who can help between appointments if I have questions or side effects?
A maintenance plan may include visits, medicine fills and nutrition support on different billing schedules. Compare the next real charge and minimum commitment for each part. Ask who will answer new symptoms or access problems between appointments.
If an offer describes an introductory medicine price, check the ongoing strength and charge separately. Your pharmacy and program can confirm the actual amount before a fill.
These are editorial comparison questions. The current program and pharmacy terms establish the actual charges for a selected plan.
Designing Longevity is a founder-led editorial publication. Our content is not medically reviewed. Source dates describe our checks, not continuous monitoring; confirm current rules and personal questions with the relevant plan or care team.
See a problem or outdated information? Tell us.